Results: The Sparks CHARMS JIA Website for Parents has been developed. Its content includes information about JIA and its treatment, including medication and therapies, as well as support and techniques to help parents manage the challenges of their child's JIA. These techniques include pain management, assisting with adherence, helping their child manage at school, family relationships and maintaining their own wellbeing. Conclusion: A comprehensive website for parents of children with JIA has been systematically developed and the next step will be to evaluate its efficacy in an RCT. Results: Preliminary data (2009 -12) reveals 92 patients were transferred to 25 adult rheumatologists. Of patients transferred, the mean age at diagnosis was 10 years (2-16) and mean age at transfer was 17 years (16)(17)(18)(19). 63% (n ¼ 58) were female and 32% (n ¼ 29) were non-caucasian. 65% (n ¼ 60) had Juvenile idiopathic arthritis. 57% (n ¼ 52) were on a DMARD/biologic during transfer. 38% (n ¼ 36) had a co-morbidity. The median (mean, range) duration between final paediatric and first adult appointment was 98 days (112.84, 17 -457). Three patients were lost to follow up. Successful transfer, defined by receipt of a letter from the first and/or second adult appointment occurred in 97% (n ¼ 90) and 62% (n ¼ 52) of cases respectively. Seven were currently being transferred and not included. Referral letter, transfer summaries, and copy letters were sent to the adult team in 72% (n ¼ 66) of cases, and copied to 73% (n ¼ 48) of patients. Conclusion: Although improvement in transfer organization is evident since 2007, variation within this service exists with significant lapses of care occurring for some patients. The potential impact on care will be discussed. Disclosure statement: The authors have declared no conflicts of interest.
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1 Academic Renal Unit, University of Bristol and 2 Departments of Paediatric Rheumatology and Paediatric Nephrology, Bristol Royal Hospital for Children, Bristol, UK Correspondence to: E. S. Sen. E-mail: ethan.sen@doctors.org.uk Introduction: LN is a serious complication of JSLE. Previous studies have suggested a role for toll-like receptor 7 (TLR7) and TLR9 in SLE pathogenesis. Podocytes are specialized cells in the glomerular filtration barrier. Biopsies from LN patients have demonstrated higher TLR7 and TLR9 expression in glomeruli compared with controls. Aims: To examine the role of TLR7 and TLR9 in podocytes to identify potential targets for more effective therapies of LN.
Method: Conditionally immortalized human podocytes were cultured. Quantitative PCR and Western blotting were used to detect TLR7 and TLR9 expression at the mRNA and protein level respectively. The effects of lipopolysaccharide (LPS), an inflammatory stimulus, imiquimod (TLR7 agonist), CpG (TLR9 agonist) and dexamethasone were examined. Phosphorylation of NFkB was assessed with Western blotting and a cell proliferation assay used to estimate cell survival. Results: Treatment of podocytes with LPS was associated with increased expression of TLR7 at the protein level with comparatively little change in TLR9. Exposure to imiquimod or CpG increased phosphorylation of NFkB. There was preliminary evidence of less phosphorylation of NFkB when cells were treated with dexamethasone prior to TLR agonists. Initial results from the cell proliferation assay suggested lower levels after imiquimod or CpG treatment for 24 h. Conclusion: This study suggests that podocytes express TLR7 and TLR9. Agonists of these receptors have effects on intracellular signalling. If confirmed, the TLR-NFkB pathway in kidney cells may be a potential target for novel therapies in LN. arthritis (JA), building their knowledge of basic information about medicines is important for future self-management. Previous work has shown that young people struggle to find effective search terms to use online. Aims: To explore young people's proficiency in spelling the names of medication used to treat juvenile arthritis. Method: Young people with JA were recruited from rheumatology clinics at a UK hospital. Participants were invited to register with a bespoke blogging website, with a unique login ID, and to create an individual blog for 8 weeks.
Results: Twenty-one young people (11-15 years) registered with the site and completed at least one blog, collectively contributing 161 entries (range 1-36 per person). Medicine names did not occur in the majority of entries (19/161). The spellings of medicine names that were mentioned varied widely (Table 1) . Conclusion: Most of the spellings suggested a phonetic approach that might result from the name being heard, but not read. In consultations where medicines are discussed, prescribers and pharmacists should build medication literacy by ensuring that young people have seen the medicine name in writing. Introduction: Young people with juvenile arthritis (JA) may have medicine regimens that do not fit with their ideas of normal. Aims: To describe the psychosocial context of medicine-taking for young people living with arthritis. Method: Young people (aged 11-15) with JA recruited from rheumatology clinics at a UK hospital wrote blogs on a bespoke Arthriting website over a 2-month period. These anonymized personal blogs included thoughts about identity, their condition, medication, and the use of health services. Qualitative data were subjected to directed content analysis. Results: Twenty-one young people took part, collectively contributing 161 blog entries. Contextual factors described in the blogs included the family, relationships with peers, and school life. Young people had help with many aspects of medication use; mothers often helped with getting supplies, setting routines, and giving medication. Family relationships sometimes affected decisions about medicines. These partnerships were viewed positively. In school, there were reports of unwanted absence, resulting from pain and swollen joints, side-effects of medicines, or scheduled appointments. For many young people, arthritis was a hidden condition, where medicine-taking was a defining element of its existence. Young people thought carefully about disclosure, especially to peers. The rheumatology team was the primary source of information. Pharmacists were not mentioned as a resource. Conclusion: Consultations with young people must take account of the psychosocial context in which they take medicines. The influence of families, school life, and peer relations and the role of community pharmacy all merit detailed exploration. Disclosure statement: The authors have declared no conflicts of interest.
Introduction: Knowledge and skills in medicine self-management are considered important by both young people and professionals. Aims: To (i) scope current patterns of medication use among young people with juvenile arthritis as documented in medical case notes (ii) map the current contribution of pharmacy to their treatment and (iii) identify gaps in data collection. Method: A cross-sectional, retrospective case-note review of 150 young people with inflammatory arthritis aged 11-18 years attending the rheumatology service at a UK hospital was undertaken. Anonymized data was collected using a structured proforma including patient and disease demographics, documentation of medicinerelated knowledge and skills, current medication use and pharmacy involvement. Results: The mean number (S.D.) of medications taken by 128 young people was 2.3 (2.1). Over a quarter of these (35/128) taking !4 different types. Over a third (53/150) were on biologics. Pharmacy issues (including local pharmacy involvement) were not identified in any case notes. Documentation of medicine management and assessment of knowledge and competency in relevant areas by professionals was poor eg allocation of responsibility of medication management was documented in only 38.3% (49/128) of notes; confirmation of knowledge of regimen was documented in less than a third of notes. Conclusion: In spite of the increasing complexity of drug regimens, this study identified major gaps in documentation of knowledge and skills relevant to the self management of such regimens by young people with JA and a limited contribution of pharmacy in this process. Further research into the potential of pharmacy to address this area is needed. Introduction: Young people with lupus often feel isolated. The need for some sort of peer support system and forum for young people with lupus to meet with each other was identified as an unmet need in our unit Aims: To enable a forum for young people with SLE to meet and interact with other. Method: In association with Lupus UK the first support group was held in September 2011. Age range 16-25 years as defined by the young people. Invites were sent to units around London and the South East. Launch of online forum April 2013. Nationwide interest. Groups outside of London beginning to develop. Results: Since September 2011 a total of 10 meetings shave been held. Participants come from all around the UK. The content of the discussions, structure of the meeting and duration of the meetings is decided by the participants. A survey conducted 1 year after the group formed revealed 6/6 (100%) were happy with the frequency, venue and length of the meetings. 5/6 (83.3%) agreed with the age limit of 16-25. Quotes from the survey about what they found most beneficial about the group included meeting other young people with Lupus, exchanging ideas,sharing their own personal experiences,learning and being less afraid of the condition I have, I think the group works brilliantly the 
